“…Cancer is one of the major causes of morbidity worldwide, and the amount of cancer cases and deaths has been found to increase rapidly as populations grow and age along with lifestyle risk factors (Torre, Siegel, Ward, & Jemal, ). Bioactive peptides have shown promising potential to inhibit numerous cancer cells at different stages, including initiation, promotion, and progression (Díaz‐Gómez, Castorena‐Torres, Preciado‐Ortiz, & García‐Lara, ). Anticancer peptides have been identified in a broad variety of plant‐derived proteins, such as amaranth (Barrio & Anon, ), lunasin from soybean antagonizing skin cancer (Hernández‐Ledesma, Hsieh, & de Lumen, ), a pentapeptide (Glu‐Gly‐Arg‐Pro‐Arg) from rice bran against colon cancer cells (Kannan, Hettiarachchy, Lay, & Liyanage, ), and rapeseed peptide specifically against morphological changes and DNA damage in HeLa cells (Xue, Liu, Wu, Zhuang, & Yu, ) as well as some animal‐derived proteins such as algae protein (Sheih, Fang, Wu, & Lin, ), anchovy protein (Y. G. Lee, Kim, Lee, Kim, & Lee, ), and peptides from tuna dark muscle against human breast cancer cells (Hsu, Li‐Chan, & Jao, ).…”